Stock data

佰研 (3205)

佰研 is a TPEx-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$35.76M, up 71.1% from a year earlier. EPS over the last four quarters totals -NT$0.12.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 佰研 in Insightr